Vital Signs Monitoring in Rehabilitation Center Patients

May 9, 2022 updated by: Eske Kvanner Aasvang, Rigshospitalet, Denmark

It is Possible to Continuous Monitor Vital Signs in Patients Discharged a Rehabilitation Center - An Observational Feasibility Study

Some patients unable to return home from hospital due to physical or mental illness will be discharged to a rehabilitation home to restore strength and rehabilitate. This study attempts to examine if it is possible to continuously monitor the vital signs in patients discharged to a rehabilitation center and whether wearable devices will detect more abnormal vital signs than the rehabilitation facility, as well as complication and readmission rates.

Study Overview

Status

Completed

Conditions

Detailed Description

Patients who are ready to leave the hospital but are deemed unable to return home are discharged to a rehabilitation center to regain strength and performance.

Vital signs are only measured when deemed necessary at the rehabilitation center, in contrast to hospital wards, where vital signs are measured intermittently and manually every 8-12 hours.

Wearable devices that continuously monitor a patient's vital signs may be able to detect patients who are deteriorating, as abnormal vital signs often precede a physiologic decline This study aims to determine whether it is possible to continuously monitor patients discharged to a rehabilitation center and detect more abnormal vital signs than measurements from the rehabilitation center. By attaching three wearable devices to 20 patients, we wished to record the vital signs for up to 96 hours, documenting abnormal vital signs as well as complications - and readmission rates.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brønshøj, Denmark, 2700
        • Center for Rehabilitering og Akutpleje - Bystævneparken

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 110 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Hospital patients discharged to a rehabilitation center

Description

Inclusion Criteria:

  • discharged to the rehabilitation center after surgery or; diagnosed with ischemic heart disease, chronic heart disease, apoplexia cerebri, chronic obstructive pulmonary disease, or diabetes.
  • Inclusion less than 72 h from rehabilitation admission

Exclusion Criteria:

  • Unable to give informed consent
  • Implanted pacemaker or cardioverter-defibrillator
  • allergic to plaster, plastic, silicone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Monitoring time
Time Frame: 96 hours
Monitoring time with data from any device
96 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SpO2 < 92%
Time Frame: 96 hours
Duration of SpO2 < 92%
96 hours
SpO2 < 88%
Time Frame: 96 hours
Duration of SpO2 < 88%
96 hours
SpO2 < 85%
Time Frame: 96 hours
Duration of SpO2 < 85%
96 hours
SpO2 < 80%
Time Frame: 96 hours
Duration of SpO2 < 80%
96 hours
Respiratory rate <5 breaths per minute
Time Frame: 96 hours
Duration of respiratory rate <5 breaths per minute
96 hours
Respiratory rate <11 breaths per minute
Time Frame: 96 hours
Duration of respiratory rate <11 breaths per minute
96 hours
Respiratory rate >24 breaths per minute
Time Frame: 96 hours
Duration of respiratory rate >24 breaths per minute
96 hours
Respiratory rate >30 breaths per minute
Time Frame: 96 hours
Duration of respiratory rate >30 breaths per minute
96 hours
Heart rate <30 beats per minute
Time Frame: 96 hours
Duration of heart rate <30 beats per minute
96 hours
Heart rate <40 beats per minute
Time Frame: 96 hours
Duration of heart rate <40 beats per minute
96 hours
Heart rate > 110 beats per minute
Time Frame: 96 hours
Duration of heart rate > 110 beats per minute
96 hours
Heart rate > 130 beats per minute
Time Frame: 96 hours
Duration of heart rate > 130 beats per minute
96 hours
Systolic blood pressure <70 mmHg
Time Frame: 96 hours
Number of systolic blood pressure <70 mmHg measurements
96 hours
Systolic blood pressure <90 mmHg
Time Frame: 96 hours
Number of systolic blood pressure <90 mmHg measurements
96 hours
Systolic blood pressure >180 mmHg
Time Frame: 96 hours
Number of systolic blood pressure >180 mmHg measurements
96 hours
Systolic blood pressure >220 mmHg
Time Frame: 96 hours
Number of systolic blood pressure >220 mmHg measurements
96 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complication
Time Frame: 30 days
Complication frequency within 30 days from study inclusion
30 days
Readmission
Time Frame: 30 days
Readmission frequency within 30 days from study inclusion
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eske K Aasvang, Dr. Med, Rigshospitalet, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2019

Primary Completion (Actual)

September 8, 2021

Study Completion (Actual)

October 8, 2021

Study Registration Dates

First Submitted

April 12, 2022

First Submitted That Met QC Criteria

April 19, 2022

First Posted (Actual)

April 26, 2022

Study Record Updates

Last Update Posted (Actual)

May 13, 2022

Last Update Submitted That Met QC Criteria

May 9, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Rigshospitalet, Copenhagen

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Comorbidities

Subscribe